Allscripts announces Veradigm AccelRx™ to help reduce patient wait times for specialty medications
Veradigm Inc. (MDRX)
Last veradigm inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allscripts.com
Company Research
Source: Business Wire
Solution simplifies complex path to Rx fulfillment CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ:MDRX) has unveiled a unique new software solution for specialty medication management, delivered by Veradigm™, its business unit focused on payer and life sciences.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200304005064/en/Veradigm’s AccelRx™ is designed to simplify meeting the requirements needed to dispense the increasing number of specialty medications being prescribed. AccelRx leverages broad industry partnerships built over decades of e-prescribing and prior authorization to deliver a user-friendly solution that is helping providers spend less time on phone calls and managing faxes while driving higher patient medication adherence.Despite representing only 3% of all prescriptions written in the U.S., in 2020, specialty medications are expected to account for up to 50% of the total spend on prescri
Show less
Read more
Impact Snapshot
Event Time:
MDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDRX alerts
High impacting Veradigm Inc. news events
Weekly update
A roundup of the hottest topics
MDRX
News
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)Business Wire
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
MDRX
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SCHEDULE
- 11/14/24 - Form SC
- MDRX's page on the SEC website